APA (7th ed.) Citation

A, F., L, S., S, O., KN, S., Y, W., J, H., . . . W, P. (2022). Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses. Cancer immunology research, 10(4), 420. https://doi.org/10.1158/2326-6066.CIR-21-0614

Chicago Style (17th ed.) Citation

A, Fedoriw, et al. "Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses." Cancer Immunology Research 10, no. 4 (2022): 420. https://doi.org/10.1158/2326-6066.CIR-21-0614.

MLA (9th ed.) Citation

A, Fedoriw, et al. "Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses." Cancer Immunology Research, vol. 10, no. 4, 2022, p. 420, https://doi.org/10.1158/2326-6066.CIR-21-0614.